PESG Research Report: Revolutionary Surgical Infection Prevention: PolyPid's D-PLEX100 Approaches Critical Phase 3 Data Readout
New report from PESG Research brand covers PolyPid*, which is tackleing the $10 billion dollar a year surgeical site infections cost with its innovative PLEX technology
New York, May 30, 2025 (GLOBE NEWSWIRE) -- PESG Research is releasing a report today examining PolyPid Ltd.*, an innovative late-stage biopharmaceutical company developing revolutionary localized drug delivery technologies for surgical infection prevention. The below report explores the company's breakthrough PLEX platform technology, its upcoming topline phase 3 data, and potential implications for transforming surgical care practices in the multi-billion dollar surgical site infection prevention market.
This report contains sponsored content, please see refer to the disclaimers and disclosures included at the end of this report.
Executive Summary
The surgical site infection (SSI) prevention landscape stands at a potential inflection point as PolyPid Ltd. prepares to announce topline results from its pivotal SHIELD II Phase 3 trial by the end of Q2 2025. The company's D-PLEX100 represents a paradigm shift in infection prevention, utilizing novel polymer-lipid encapsulation matrix (PLEX) technology to deliver sustained antibiotic release directly at surgical sites for 30 days. With SSIs affecting up to 30% of colorectal surgeries and imposing substantial healthcare costs estimated at $10 billion annually in the US and EU, successful development of D-PLEX100 could address a critical unmet medical need. The FDA's assignment of Breakthrough Therapy, Fast Track, and Qualified Infectious Disease Product (QIDP) designations underscores the regulatory recognition of this approach's potential significance.The Critical Challenge of Surgical Site Infections
Surgical site infections remain one of healthcare's most persistent challenges, representing 20% of all healthcare-associated infections in US hospitals. Despite advances in surgical techniques and prophylactic protocols, SSI rates in high-risk procedures like colorectal surgery can reach 30%, leading to extended hospital stays of 7-11 additional days and mortality risk increases of 2-11 fold. The economic burden is staggering, with direct costs averaging $11,000-26,000 per infection and total annual costs reaching approximately $10 billion in the US alone.
Current prevention strategies rely primarily on systemic antibiotic prophylaxis administered intravenously 30-60 minutes before surgery. However, this approach faces fundamental limitations. Surgical incisions disrupt local blood flow, significantly limiting antibiotic penetration to the precise site where infections occur. Moreover, systemic administration exposes patients to higher drug concentrations throughout the body, potentially increasing toxicity risks and contributing to antimicrobial resistance development.
PLEX Technology: A Novel Approach to Localized Drug Delivery
PolyPid's proprietary PLEX technology represents a sophisticated advancement in controlled drug delivery systems. The platform creates thousands of alternating layers of biocompatible polymers and lipids that physically embed active pharmaceutical ingredients. As these outer layers gradually disintegrate upon exposure to body fluids, they enable precise, predetermined drug release rates spanning several days to months.
For D-PLEX100, this technology pairs with doxycycline, a broad-spectrum antibiotic effective against both gram-positive and gram-negative bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and other antibiotic-resistant strains. The formulation achieves local antibiotic concentrations 10-115 times higher than systemic administration while using only a fraction of the total drug amount, potentially minimizing systemic exposure and associated side effects.
Clinical Development Progress and Regulatory Recognition
The clinical development program for D-PLEX100 has demonstrated encouraging signals across multiple surgical contexts. In Phase 2 abdominal surgery trials, D-PLEX100 plus standard of care achieved a statistically significant 59% reduction in the primary endpoint compared to standard of care alone (p=0.0086). Perhaps more notably, the treatment group experienced zero deaths compared to five in the control arm within 60 days post-surgery.
The pivotal SHIELD I Phase 3 trial, while not meeting its primary endpoint in the full intent-to-treat population, revealed compelling efficacy in a pre-specified subgroup analysis. Among patients with large surgical incisions (>20 cm), D-PLEX100 demonstrated a statistically significant 54% reduction in the composite primary endpoint of SSIs, reinterventions, and mortality (p=0.0032). This finding directly informed the design of the ongoing SHIELD II trial, which focuses specifically on this higher-risk patient population.The FDA's regulatory designations reflect recognition of D-PLEX100's potential significance. Breakthrough Therapy designation is reserved for drugs that demonstrate substantial improvement over existing treatments for serious conditions. Fast Track designation facilitates more frequent FDA communications and potentially accelerated review timelines. The QIDP designation provides additional market exclusivity incentives for addressing antimicrobial resistance challenges.
SHIELD II: A Potentially Definitive Study
The ongoing SHIELD II Phase 3 trial represents a carefully designed study incorporating lessons learned from SHIELD I. Following an independent Data Safety Monitoring Board's review of unblinded efficacy data from the first 430 enrolled patients, the board recommended concluding the study at 800 patients—the lowest sample size reassessment option available. This recommendation, while requiring additional enrollment beyond the initially planned 624 patients, may suggest positive efficacy trends in the analyzed interim data.
The study's multinational design spans approximately 60 centers across the United States, Europe, and Israel, enhancing the generalizability of results across different healthcare settings and patient populations. The primary endpoint focuses on a composite of SSI events, reinterventions, and mortality within 30 days post-surgery, as adjudicated by an independent committee.
Broader Industry ImplicationsSuccess of D-PLEX100 could catalyze broader adoption of localized drug delivery approaches in surgical settings. The technology's platform nature suggests potential applications beyond infection prevention, including localized chemotherapy delivery through the company's OncoPLEX program, currently in preclinical development for solid tumor treatment.
The substantial market opportunity—with approximately 12 million eligible procedures annually in the US and 8 million in Europe—underscores the potential healthcare impact. PolyPid has already secured European commercialization rights through a partnership with Advanz Pharma, valued at up to $115 million plus royalties, while advancing discussions for US market partnerships.
Conclusion
As the pharmaceutical industry grapples with antimicrobial resistance and healthcare systems seek cost-effective solutions to persistent clinical challenges, D-PLEX100's approaching data readout represents a potentially significant milestone. The convergence of compelling preclinical and early clinical data, regulatory recognition, and substantial unmet medical need positions this development as one to monitor closely in the evolving landscape of surgical infection prevention.Recent News Highlight from PolyPid: PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections >> Click here to Subscribe for more updates like this or go to https://www.pesgresearch.com/subscribe * Legal Disclaimer & Disclosure: Nothing in this report constitutes medical, financial or any form professional or licensedadvice. This report is published by 'PESG Research', a digital promotional content brand who's operators are compensated to provide digestable and favorabel coverage of companies. This report contains and is a form of paid promotional content or advertising for PolyPid Ltd and was produced as part of the fee's they pay PESG's operators, Arx Advisory Ltd. This report has not been reviewed or approved by PolyPId prior to publication and it does not represent an official communication from PolyPid. The operators of PESG Research received or are expected to receive a monthly recurring fee of five thousand united states dollars via wire transfer from PolyPid as part of an ongoing agreement starting May 1, 2025 in return for distribution and promotional coverage services, and receive additional monthly compensation for non promotional unrelated data and advisory services on top of that. Please review the full disclaimers and compensation disclosures here for further details: redditwire.com/terms. Readers are advised to refer to the official materials of the company aforementioned. The report should not be treated as objective.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
18 minutes ago
- Business Upturn
Syntiant to Demonstrate Ultra-Low-Power Automotive AI Innovations at AutoSens and InCabin 2025
IRVINE, Calif., June 10, 2025 (GLOBE NEWSWIRE) — Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will showcase two of its vehicle sensing technologies at AutoSens and InCabin 2025, June 10-12 at Huntington Place in Detroit (Booth #210). Syntiant's multimodal automotive solutions are designed to enhance vehicle safety and user experiences by enabling always-on audio and vision intelligence at the edge, without draining the battery or relying on cloud connectivity. Live demonstrations will include: Low-power camera security system . Ideal for applications such as parked vehicle monitoring and fleet management, this AI perimeter security solution keeps dash or external cameras in an ultra-low-power standby mode while continuously monitoring for specific audio or visual cues, such as footsteps, voices or motion near the vehicle. Upon detection, the system instantly activates high-resolution cameras to begin recording at under 200 mW, preserving energy while improving real-time incident capture. In contrast, traditional always-on security systems can draw over 100 watts , limiting them to electric vehicles with large batteries. Syntiant's solution delivers comparable performance at a fraction of the power, enabling always-on security for virtually any vehicle. . Ideal for applications such as parked vehicle monitoring and fleet management, this AI perimeter security solution keeps dash or external cameras in an ultra-low-power standby mode while continuously monitoring for specific audio or visual cues, such as footsteps, voices or motion near the vehicle. Upon detection, the system instantly activates high-resolution cameras to begin recording at under 200 mW, preserving energy while improving real-time incident capture. In contrast, traditional always-on security systems can draw over 100 watts limiting them to electric vehicles with large batteries. Syntiant's solution delivers comparable performance at a fraction of the power, enabling always-on security for virtually any vehicle. External sound detection using vibration sensors. Traditional microphones placed outside of a vehicle are prone to failure in harsh environments. Rain, dust, snow and even car washes might permanently damage the device. Syntiant's V2S vibration sensors mounted on a vehicle's door, windshield or trunk, detect motions caused by external sounds, enabling features like emergency vehicle detection and hands-free voice commands (e.g., 'open trunk'), without the exposure-related limitations of conventional microphones. By effectively turning the vehicle's surface into the microphone, the Syntiant V2S provides a durable and reliable alternative for external sound detection. 'Enhanced sensing capabilities are essential to meet the demands of smarter vehicles, especially when driving conditions are less than ideal,' said Greg Doll, SVP and GM of Syntiant's sensors business unit. 'By integrating sensors, AI hardware and software, we have developed low-power automotive intelligence that can enable vehicles to be more responsive to their surroundings, and ultimately more useful to drivers and passengers.' Syntiant's complete automotive solutions are powered by a combination of its Neural Decision Processors, ML models, sensors and microphones. These technologies power a broad range of intelligent automotive features, including voice and siren detection, blind spot alerts, facial recognition, battery management, in-cabin monitoring and other Advanced Driver Assistance Systems (ADAS). More information about Syntiant's automotive solutions can be found at AutoSens and InCabin 2025 OEMs and Tier 1 suppliers can register at no cost by visiting Partners, including distributors, representatives and design partners, are eligible for a 30% discount, available upon request by emailing [email protected]. To schedule a private demo or meeting with Syntiant (Booth #210), please contact [email protected]. About Syntiant Founded in 2017 and headquartered in Irvine, Calif., Syntiant® is Making Edge AI a Reality™ by delivering highly efficient processor, sensor and software solutions. With more than 100 million purpose-built silicon and ML models deployed, along with billions of MEMS microphones and sensors, Syntiant's technology is powering edge AI applications for speech, audio, sensor and vision processing worldwide. From earbuds to automobiles, the company's turnkey solutions enable advanced edge AI capabilities across diverse consumer and industrial use cases. More information on the company can be found by visiting or by following Syntiant on X @Syntiantcorp or LinkedIn. Media Contact: George Medici/Natalie MuPondelWilkinson Inc. [email protected] or [email protected] 310-279-5968


Business Upturn
18 minutes ago
- Business Upturn
Ontario, Canada Filtration Manufacturer Camfil Demonstrates Significant Cost Savings for Ontario School Air Filtration Systems
Toronto, Ontario, June 10, 2025 (GLOBE NEWSWIRE) — Camfil Canada, a leading provider of commercial and industrial air filtration solutions, today announced the publication of a comprehensive case study demonstrating substantial cost savings achieved through advanced air filter implementation in Ontario school facilities. The research highlights how Canadian educational institutions can reduce operational expenses while improving indoor air quality for students and staff. Addressing Canadian School Air Quality Challenges Ontario schools face unique air quality management challenges, including extreme seasonal temperature variations, budget constraints, and increasing focus on student health and improving the learning environment. The new case study provides a detailed analysis of how proper air filter selection and implementation can address these challenges while delivering measurable financial benefits. 'Canadian schools operate under significant budgetary pressures while maintaining responsibility for student and staff health,' said Joshua Gutherie, Air Quality Expert at Camfil Canada. 'Our case study demonstrates that investing in high-efficiency air filtration technology delivers both improved air quality and substantial cost savings for Ontario schools.' Documented Cost Savings in Ontario Educational Facilities The published case study presents a detailed financial analysis of implementing the plan for Ontario schools, including: ● Energy Cost Reductions: Quantified savings in heating and cooling expenses through improved HVAC system efficiency ● Maintenance Cost Decreases: Reduced filter replacement frequency and HVAC system maintenance requirements ● Extended Equipment Life: Protection of HVAC systems leading to deferred capital replacement costs ● Operational Efficiency Improvements: Streamlined maintenance procedures and reduced labour requirements The study specifically addresses the impact of Ontario's energy costs and seasonal operational demands on the performance and economics of school air filtration systems. Supporting Student Health and Learning Outcomes Beyond cost savings, the case study documents improvements in indoor air quality that directly benefit student health and academic performance. Research continues to demonstrate the connection between improved air quality and enhanced learning environments, making air filtration investments valuable from both financial and educational perspectives. 'Ontario schools are increasingly recognizing that air quality investments support both fiscal responsibility and educational excellence,' noted Guthrie. 'Our case study provides the data and analysis that school boards need to make informed decisions about air filtration technology.' Advanced Filtration Solutions for Canadian Schools The case study features a detailed analysis of air filtration technologies specifically suited to Canadian educational environments, including: ● High-Efficiency Particulate Filters: Engineered to handle Ontario's seasonal allergen and particulate loads while minimizing energy consumption ● Extended Service Life Filters: Designed to maintain performance despite challenging Canadian environmental conditions. This includes fewer replacements, with some filters lasting up to a year in Ontario schools, compared to three months for competing filters. ● Energy-Efficient Filter Media: Optimized for Canadian HVAC systems and operations ● Each solution addresses the specific requirements of Ontario schools, including compliance with provincial building codes, accommodating extreme temperature variations, and optimizing energy cost savings. Practical Implementation Guidance for Ontario School Boards The published case study provides actionable implementation strategies for Ontario educational facilities, addressing common concerns, including: ● Budget Planning: ROI calculations and payback period analysis for different filter upgrade scenarios ● Seasonal Considerations: Implementation of timing recommendations for Ontario school operational schedules ● Maintenance Training: Guidance for school staff on optimizing filter performance and longevity ● Compliance Requirements: Alignment with Ontario building codes and educational facility standards Supporting Ontario's Educational Infrastructure The case study reflects Camfil Canada's commitment to supporting Ontario's educational sector through practical air quality solutions that address both health and financial priorities. As Ontario schools continue to focus on creating optimal learning environments while managing operational costs, evidence-based air filtration strategies provide measurable benefits. The research also addresses emerging considerations for Ontario schools, including enhanced focus on indoor air quality following public health awareness campaigns and increasing emphasis on energy efficiency in public buildings. Canadian Educational Resource Availability The complete Ontario schools air filtration case study is available now through Camfil Canada's website at The resource includes downloadable implementation guides, cost calculation tools, and technical specifications specifically developed for Canadian educational facilities. About Camfil Canada Ontario, Canada Filtration Manufacturer Camfil Camfil Canada is a leading provider of air filtration solutions for commercial, industrial, and institutional applications across Canada. With comprehensive experience in Canadian building environments, the company provides engineered solutions for challenging air quality requirements, including educational facilities, healthcare institutions, commercial buildings, and industrial operations. The company maintains distribution and service capabilities across Canada, providing technical support, installation guidance, and maintenance services from coast to coast. Camfil Canada is part of the global Camfil Group, recognized worldwide for innovation in air filtration technology and commitment to clean air solutions. For more information about Camfil Canada's educational facility air filtration solutions, visit the Camfil Canada Website or contact the Canadian educational applications team at 905-660-0688. Media Contact: Phillip Ilijevski Camfil Canada Inc. Phone: 437-929-1161 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same.


Business Upturn
18 minutes ago
- Business Upturn
Lucasys Income Tax Suite Launches on SAP® Store
By GlobeNewswire Published on June 10, 2025, 22:29 IST ATLANTA, June 10, 2025 (GLOBE NEWSWIRE) — Lucasys, a leading cloud software and service provider for rate-regulated utilities, today announced that its suite of tax applications – including Lucasys Tax Depreciation, Deferred Tax, TBBS, and Copilot – is now available on the SAP® Store, the digital marketplace for SAP and partner offerings. This milestone follows Lucasys' recent partnership within the SAP® PartnerEdge® Open Ecosystem. By integrating with SAP S/4HANA® and other SAP solutions, these applications provide a seamless experience for customers managing complex tax and regulatory requirements. 'Bringing Lucasys Tax applications to the SAP Store underscores our commitment to fostering innovation and flexibility for utilities and asset-intensive businesses,' said Daniel Chang, Chief Operating Officer at Lucasys. 'With this integration, customers can enhance their SAP environments with modern, purpose-built tax solutions that simplify processes, improve compliance, and unlock actionable insights.' Lucasys' tax applications are designed to streamline and automate critical tax processes, including tax depreciation and deferred tax management, while delivering unparalleled usability and security. The modular architecture and deep regulatory support of these solutions ensure that customers can adapt to changing industry demands and achieve long-term operational excellence. Key Features of the Lucasys Income Tax Suite: Integrated Tax Applications: Single integrated experience across tax applications used for tax accounting, tax compliance, and tax forecasting. Enhanced Usability: Simplified workflows reduce the data maintenance burden for end users and facilitate onboarding and training. Flexible Reporting: Robust, user-driven reporting allows for greater visibility and data confidence. Data-Driven Insights: Provides actionable analytics to facilitate strategic tax planning. Scalable Solutions: Tailored for large enterprises and asset-intensive organizations. To learn more about Lucasys' solutions and their availability in the SAP Store, visit and SAP® Store. About Lucasys Lucasys provides software and technology-enabled services to empower finance, accounting, and tax professionals in asset-intensive industries to optimize the financial performance of their fixed assets and proactively meet changing regulatory and compliance requirements. With a core focus on rate-regulated utilities, Lucasys provides the industry and domain expertise utilities require to meet their business objectives. To learn more about Lucasys, visit A photo accompanying this announcement is available at Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.